Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Markets
Stocks
Sectors
Investing Tools
Overview
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
ASTRAZENECA PLC (NY: AZN)
+0.9800 (+2.272%)
at
44.11
2,755,875 in Volume
Add to:
My Watchlist
Data as of 06:40 PM EST Feb 9,2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
Today's Open 44.27
Bid (Size) 43.06 (200)
Ask (Size) 44.60 (600)
Prev. Close 43.13
Today's Range 43.67 - 44.57
52wk Range 29.96 - 50.70
Shares Outstanding 1,448,000,000
Morningstar Profile
View Full Profile
ASTRAZENECA PLC
The company discovers, develops, manufactures and markets prescription pharmaceuticals and biological products in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide.
Healthcare
Drug Manufacturers - Major
Exchange Traded NY
Market Cap 63.87B
Related Companies AZND GSK AZNCF LRLCF
Featured News
Read More
US FDA Approves New Indication for CRESTOR(R) (rosuvastatin calcium)
Feb 08, 2010
Approval based on JUPITER study which evaluated CRESTOR in a previously unstudied population Read More
from PRNewsWire News Releases
Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics'
Jan 29, 2010
Phase 3 Pivotal Trial Demonstrated 26 Percent Relative Reduction in RSV Hospitalization; 50 Percent Relative Reduction in Incidence of RSV Outpatient Visits Read More
from PRNewsWire News Releases
Featured News
Read More
AstraZeneca CEO Interviewed on Q4 and Full-Year Results 2009
Jan 28, 2010
from PRNewsWire News Releases
Critical Alerts for AIG, Procter & Gamble, Gilead Sciences, Thermo Fisher Scientific, and AstraZeneca Released by Seven Summits Research
Jan 20, 2010
from PRNewsWire News Releases
AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
Jan 18, 2010
from PRNewsWire News Releases
AstraZeneca Offers Online Enrollment and Additional Improvements to Patient Assistance Program
Jan 13, 2010
from PRNewsWire News Releases
More News
Read More
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA